Prediction of area under the curve for a p-glycoprotein, a CYP3A4 and a CYP2C9 substrate using a single time point strategy: assessment using fexofenadine, itraconazole and losartan and metabolites

The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly

(2015) A. Corsonello et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antidiabetic Medications and Polypharmacy

(2015) Emily P. Peron et al.   CLINICS IN GERIATRIC MEDICINE

Innovative approaches to optimizing the delivery of vancomycin in individual patients

(2014) Manjunath P. Pai et al.   ADVANCED DRUG DELIVERY REVIEWS

Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots

(2014) M Bosilkovska et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin

(2014) C. Magis-Escurra et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Potential Drug-Drug Interactions in Infant, Child, and Adolescent Patients in Children's Hospitals

(2014) J. Feinstein et al.   PEDIATRICS

Soluble Itraconazole in Tablet Form Using Disordered Drug Delivery Approach: Critical Scale-up Considerations and Bio-equivalence Studies

(2013) Shankar Swaminathan et al.   AAPS PHARMSCITECH

Method of variability optimization in pharmacokinetic data analysis

(2013) Tomasz Grabowski et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Mechanisms of Pharmacokinetic Enhancement Between Ritonavir and Saquinavir; Micro/Small Dosing Tests Using Midazolam (CYP3A4), Fexofenadine (p-Glycoprotein), and Pravastatin (OATP1B1) as Probe Drugs

(2013) Ichiro Ieiri et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Limited Sampling Model for Advanced Mycophenolic Acid Therapeutic Drug Monitoring After Liver Transplantation

(2013) Pieter Langers et al.   THERAPEUTIC DRUG MONITORING

Lack of Indinavir Effects on Methadone Disposition Despite Inhibition of Hepatic and Intestinal Cytochrome P4503A (CYP3A)

(2012) Evan D. Kharasch et al.   ANESTHESIOLOGY

The Observed Correlation between in vivo Clinical Pharmacokinetic Parameters and in vitro Potency of VEGFR-2 Inhibitors

(2012) B. Benjamin et al.   ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH

Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics

(2012) E D Kharasch et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effects of CYP2C9*1/*3 and *1/*13 on the pharmacokinetics of losartan and its active metabolite E-3174

(2012) Jung-Woo Bae et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics

(2011) Jung-woo Bae et al.   ACTA PHARMACOLOGICA SINICA

Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers

(2011) Yumiko Akamine et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology

(2011) Jennifer H. Martin et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetic evaluation of losartan

(2011) Michel Burnier et al.   Expert Opinion on Drug Metabolism & Toxicology

Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose

(2011) Ichiro Ieiri et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Influence ofPanax ginsengon Cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) Activity in Healthy Participants

(2011) Christine Y. Malati et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Simultaneous determination of phthalates and adipates in human serum using gas chromatography-mass spectrometry with solid-phase extraction

(2010) Zhi-Yong Guo et al.   BIOMEDICAL CHROMATOGRAPHY

Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers

(2010) Kyoung-Ah Kim et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren

(2010) Tuija Tapaninen et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Evaluation of Single-Point Sampling Strategies for the Estimation of Moclobemide Exposure in Depressive Patients

(2010) Anita Rakic Ignjatovic et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Increased Oral Bioavailability of Itraconazole and Its Active Metabolite, 7-Hydroxyitraconazole, When Coadministered With a Vitamin C Beverage in Healthy Participants

(2010) Soo Kyung Bae et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans

(2010) Junko Imanaga et al.   Pharmacogenetics and Genomics

Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil

(2009) Takashi Sakugawa et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers

(2009) Kyoung-Ah Kim et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers

(2009) Yang Han et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

ESRD Impairs Nonrenal Clearance of Fexofenadine but not Midazolam

(2009) T. D. Nolin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Pharmacokinetics, safety and tolerability of an oral suspension of fexofenadine for children with allergic rhinitis

(2008) Nathan Segall et al.   ALLERGY AND ASTHMA PROCEEDINGS

The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers

(2008) Tomonori Tateishi et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The Effect of Bucolome, a CYP2C9 Inhibitor, on the Pharmacokinetics of Losartan

(2008) Mariko Kobayashi et al.   Drug Metabolism and Pharmacokinetics

Probenecid, but Not Cystic Fibrosis, Alters the Total and Renal Clearance of Fexofenadine

(2008) Shanshan Liu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Involvement of Multiple Efflux Transporters in Hepatic Disposition of Fexofenadine

(2008) S. Matsushima et al.   MOLECULAR PHARMACOLOGY